BIO-key International will host its Q1 2025 investor call on May 16, following results release post-market on May 15.
Quiver AI Summary
BIO-key International, Inc. will hold its first quarter 2025 investor call on May 16 at 10 a.m. ET, following the release of its financial results after market close on May 15. The call will be led by Chairman and CEO Mike DePasquale and CFO Cecilia Welch, and will include a Q&A session. Investors can join the call via a U.S. or international dial-in number, or through a live webcast that will also be available for replay for three months. BIO-key specializes in identity and access management solutions with biometric capabilities, supporting over 40 million users with various authentication options aimed at enhancing security and accessibility.
Potential Positives
- BIO-key International, Inc. is hosting its first quarter 2025 investor call, indicating transparency and open communication with stakeholders.
- The company is expected to release its financial results, which may provide insights into its performance and strategic direction.
- The executive team, including the Chairman & CEO and CFO, will lead the call, showcasing leadership involvement and commitment to investor relations.
Potential Negatives
- Providing a future event without sharing the current quarter's results may lead to speculation about potential underperformance or disappointing financial metrics.
- The press release does not highlight any significant achievements or growth metrics, which may raise concerns among investors about the company's current market position.
- The lack of specific financial data or operational updates in the release prior to the earnings call may diminish investor confidence in the company’s transparency and performance.
FAQ
When is BIO-key's first quarter 2025 investor call?
BIO-key's investor call is scheduled for Friday, May 16th at 10 a.m. ET.
How can I access the investor call?
You can access the investor call by dialing 1-877-418-5460 for U.S. participants or 1-412-717-9594 for international callers.
Who will be leading the investor call?
The investor call will be led by Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO of BIO-key.
Will there be a replay available for the investor call?
Yes, a live webcast and a replay will be available for three months after the call.
What is BIO-key's primary business focus?
BIO-key specializes in Identity and Access Management solutions with a focus on biometric authentication technologies.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BKYI Hedge Fund Activity
We have seen 6 institutional investors add shares of $BKYI stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 250,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $427,500
- CITADEL ADVISORS LLC added 20,330 shares (+inf%) to their portfolio in Q4 2024, for an estimated $34,764
- GEODE CAPITAL MANAGEMENT, LLC added 11,195 shares (+inf%) to their portfolio in Q4 2024, for an estimated $19,143
- XTX TOPCO LTD removed 10,223 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,065
- UBS GROUP AG removed 6,307 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $10,784
- CITIGROUP INC added 2,550 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,360
- TOWER RESEARCH CAPITAL LLC (TRC) added 1,701 shares (+32.7%) to their portfolio in Q4 2024, for an estimated $2,908
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric capabilities, will host its first quarter 2025 investor call on Friday, May 16th at 10 a.m. ET. Results will be released after market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session.
| Call Details | |
|
Date / Time:
|
Friday, May 16th at 10 a.m. ET |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l |
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months |
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6501265 |
About BIO-key International, Inc. ( www.BIO-key.com )
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts
William Jones, David Collins
Catalyst IR
[email protected]
212-924-9800
